PMID: 9555532Apr 29, 1998Paper

Peripheral blood versus bone marrow for hematopoietic cell transplantation

Current Opinion in Oncology
T Repka, D Weisdorf

Abstract

Peripheral blood stem cell transplantation is being used more frequently in both the autologous and allogeneic setting. The use of cytokines either alone or in conjunction with chemotherapy priming has made peripheral procurement of the stem cells through apheresis possible. Differences exist both in the composition of the graft and in subsequent posttransplantation immune reconstitution between peripheral blood stem cells and bone marrow. Reliable estimates of the comparative incidence of acute and chronic graft-versus-host disease following blood or marrow allogeneic transplantation are not yet available.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.